The two-time Olympic gold medallist is among 36 per cent of people with the condition who are clinically diagnosed ...

Greenwich LifeSciences (GLSI) stock surges 23% premarket after promising Phase 3 results for GLSI-100, a breast cancer ...

It’s estimated that 1 in 100 people have it; however, only 36% with the condition are clinically diagnosed, according to Coeliac UK.

For roughly one in every hundred people, food containing even the smallest amounts of gluten can deliver a gutful of hurt and ...

Immunotherapy has revolutionized the way physicians treat patients with cancer. This form of cancer treatment aims to direct the immune system toward the r | Immunology ...

Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically ...

Imagine a previously unknown bug—new to our immune defenses—that suddenly emerged and rapidly spread all over the globe, ...

Coeliac disease is an autoimmune condition where the body attacks ... Having certain gene markers, namely HLA-DQ2 or HLA-DQ8, can also increase your risk of developing the condition.

Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for ...